SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community rallies around the token's resilience and potential within the Solana ecosystem. Discussions highlight WAGMI's strong holder base and its ability to maintain stability during market fluctuations, with many anticipating significant gains as Solana's liquidity expands. Some users are suggesting that it should be added to watchlists.

This is a legacy token commemorating the pseudonym Satoshi Nakamoto.

Satoshi Nakamoto

$SATOSHI is trending as the community rallies around the tokenization of the pseudonymous Bitcoin creator, Satoshi Nakamoto, emphasizing the narrative's significance and potential. The community buzzes about an upcoming feature on the Mario Nawfal space, anticipating increased attention and a potential price surge. Many believe $SATOSHI represents the spirit of crypto and is destined to become a blue-chip meme coin.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple's stock is trending due to post-earnings volatility, with initial after-hours gains fading quickly. Community discussions revolve around whether the stock can hold its gains, especially with concerns about iPhone sales and China revenue. Some traders believe the stock is overvalued, while others are optimistic about future growth.

Lumen Technologies, Inc. is an investment holding company, which engages in the provision of integrated communications to residential and business customers. It operates through the Business and Mass Markets segments. The Business segment provides products and services under four sales channels to enterprise and commercial customers. The Mass Markets segment focuses on consumer and small business customers. The company was founded in 1930 and is headquartered in Monroe, LA.

Lumen Technologies Inc

Lumen Technologies is trending as community members discuss the company's strong free cash flow and potential AI infrastructure play, especially highlighting its partnership with Palantir. Bulls are optimistic about Lumen's future, citing insider buying and potential for significant growth. Some traders caution about debt levels and potential consolidation after the recent surge.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors discuss its potential for a breakout following recent consolidation, with community members highlighting upcoming catalysts and overall bullish sentiment despite some concerns about short positions and past performance. Discussions also center on the company's growth prospects, revenue guidance, and potential impact of the CMS policy. Some traders are expressing frustration with the stock's sideways movement and look for a breakout soon.

Solana is a highly functional open source project that banks on blockchain technology’s permissionless nature to provide decentralized finance (DeFi) solutions. It is a layer 1 network that offers fast speeds and affordable costs. While the idea and initial work on the project began in 2017, Solana was officially launched in March 2020 by the Solana Foundation with headquarters in Geneva, Switzerland.

Solana

Solana is trending as the community focuses on its structural strength and liquidity depth, while also keeping an eye on accumulation patterns. Bullish sentiment is fueled by the anticipation of capital rotation into high-conviction assets within the Solana ecosystem, particularly meme coins. Some traders are noting the potential impact of a government re-opening.

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is gaining traction, with community members highlighting recent bullish activity and encouraging others to load up. Some are pointing to potential catalysts like the US Treasury General Account and its effect on market liquidity. The coin is frequently mentioned alongside other crypto plays and the $WAGMI sentiment.

Boqii Holding Ltd. operates as a holding company with interest in operating online pet stores. It provides services through its subsidiaries. The company was founded by Liang Hao, Tang Yingzhi, and Chen Di in December 2007 and is headquartered in Shanghai, China.

Boqii Holding Limited - Ordinary Shares - Class A

Boqii Holding Limited - ADR

Boqii Holding is experiencing significant volatility, leading to active discussions about potential manipulation and whether it's a "pump and dump" scheme. The stock's dramatic price swings are prompting traders to debate entry and exit strategies, with some anticipating further upward momentum while others warn of a potential crash. Community members are also noting the stock's history of sharp halts and comparing it to other volatile Chinese stocks.

Coinbase Global, Inc. engages in the provision of a trusted platform that serves as a compliant on-ramp to the onchain economy and enables users to engage in a wide variety of activities with their crypto assets in both proprietary and third-party product experiences enabled by access to decentralized applications. It offers consumers primary financial account for the cryptoeconomy, institutions a full-service prime brokerage platform with access to deep pools of liquidity across the crypto marketplace, and developers a suite of products granting access to build onchain. The company was founded by Brian Armstrong and Fred Ernest Ehrsam in May 2012 and is headquartered in New York, NY.

Coinbase Global Inc - Ordinary Shares - Class A

Coinbase Global Inc

Coinbase ($COIN) is trending amid anticipation for upcoming earnings, with community members weighing in on potential outcomes and key levels to watch. Bullish sentiment is fueled by rising crypto prices and potential regulatory tailwinds, while others express concerns about valuation and historical post-earnings performance. A new Citigroup partnership, focused on stablecoin payments, has also sparked discussion about Coinbase's role in the evolving financial landscape.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as investors digest recent earnings and forward guidance, particularly around Bitcoin holdings and a $150K year-end target. Community chatter highlights the potential for a short squeeze and S&P 500 inclusion, while some express skepticism about the company's business model and reliance on Bitcoin's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger

NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger PR Newswire ZURICH and NESS ZIONA, Israel, Oct. 30...

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs

NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs NLS Pharmaceutics Expands CNS Pipeline With AEX-6xx Series Developed by Aexon Labs PR Newswire ZURICH, Oct. 30, 2025...

NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger

NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation Support for ITOL-102 Diabetes Program Following Merger NLS Pharmaceutics and Kadimastem Highlight Continued BIRD Foundation...

NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem

NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name Change in Connection with Proposed Merger with Kadimastem NLS Pharmaceutics Ltd. Announces 1-for-10 Reverse Share Split and Name...

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares

NLS Pharmaceutics and Kadimastem Announce Completion of Material Conditions Precedent for Merger Transaction and Delisting Date of Kadimastem's Shares NLS Pharmaceutics and Kadimastem Announce...

NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies

NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies NLS Pharmaceutics and Kadimastem Announce...

NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025

NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30, 2025 NLS and Kadimastem Announce Receipt of Nasdaq Approval; Merger Expected to Close on October 30...

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment

Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its Type 1 Diabetes Treatment Kadimastem and iTolerance Successfully Complete Pre-IND Meeting with the FDA for its...

NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies

NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond GLP-1 Therapies NLS Pharmaceutics and Kadimastem Unveil Multi-Target Approach to Diabetes, Expanding Beyond...

Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics

Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics Kadimastem Shareholders Approved the Merger with NLS Pharmaceutics PR Newswire ZURICH and NESS ZIONA, Israel, Jan. 31, 2025 ZURICH...

NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. Its product portfolio includes Quilience, a treatment for excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol, a treatment for attention deficit hyperactivity disorder. The company was founded by Ronald Hafner, Eric Konofal, and Alexander Zwyer on June 10, 2015 and is headquartered in Zurich, Switzerland.

NLS Pharmaceutics Ltd

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits Polls

NLSP is trending due to its recent merger with Kadimastem, leading to a ticker change to NCEL and a planned reverse stock split, causing confusion and volatility. The community is actively discussing the implications of the merger, potential short squeezes, and the impact of broker adjustments following the reverse split. Some traders report accidental short positions and are strategizing around potential price corrections and the new stock's valuation.

NLSP
NLS Pharmaceutics Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest NLSP News

NLSPNLS Pharmaceutics Ltd